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Abstract
Background
Urogenital infection with Chlamydia trachomatis(CT) is one of the most common bacterial
sexually transmitted infections (STIs) world-wide, especially in developing nations where
routine laboratory diagnosis is unavailable. Little is known about the epidemiology of this
infection in Ethiopia where other STIs are prevalent. This study was conducted to determine
the prevalence and associated factors of CT infection among women of reproductive age.
Methods
A cross-sectional study was conducted among 322 consecutive women aged between 15–
49 years at Hawassa University Referral Hospital from November 2014 to April 2015. Data
on socio-demography and potential risk factors for genital infection were collected using
structured questionnaires. Moreover, endocervical swabs were collected from all partici-
pants, screened for CT antigen using rapid immunochromatography assay, and cultured fol-
lowing the standard bacteriological method to isolate Neisseria gonorrhoeae.
Result
In this study, the overall prevalence of CT antigen and N. gonorrhoeae infection was 61
(18.9%) and 1(0.31%), respectively. Women aged 15–24 years had the highest prevalence
of CT infection (24.2%), followed by those aged 25–34 years (16.8%) and those aged 35–49
years (9.6%). CTinfection was associated with women who had unprotected sex within the
last six months (aOR = 3.459; 95% CI = 1.459–8.222) and were sexually active for 6–10
years (aOR = 3.076; 95% CI = 1.152–8.209). None of the clinical symptoms and diagnoses
was significantly associated with CT antigen positivity.
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Conclusions
The high prevalence of genital CT infection in this study highlights the need for further large-
scale studies on the general population. Thus, screening of women regardless of their
symptoms should be in place.
Background
Sexually transmitted infections (STIs) are major public health problems in developing coun-
tries where diagnostic and treatment service is limited [1]. Chlamydia trachomatis(CT) and
Neisseria gonorrhoeae are the most common causes of genitourinary tract infection in young
adults around the world [2]. Globally, over 90 million new CT infections were reported annu-
ally [3]. CT infection is known to cause cervicitis and non-gonococcal urethritis. Women with
cervical chlamydial infection are at a risk for pelvic inflammatory disease (PID), which can
lead to long—term reproductive sequelae, such aschronic pelvic pain, ectopic pregnancy and
infertility [4]. However, about 75% of women with CT infection remain asymptomatic and
because they are unaware of their infection, they do not seek treatment [5]. Consequently,
unrecognized and untreated individuals remain infectious for months during which there is
an increased chance of transmitting the pathogen to their sexual partners.
As part of an effort to reduce the transmission and clinical consequences of chlamydial
infection, the Center for Disease Control and Prevention (CDC) recommends annual screen-
ing of all sexually active women aged less than 25 years [6], and study has shown thatannual
screening would prevent 61% of CT-related PID in women who became infected with CT [7].
However, the current practice in Ethiopia is based on syndromic case management by adopt-
ing the world health organization(WHO) recommendation, despite its poor specificity and
positive predictive values [1].
In Ethiopia, the impact of CT infection is not well known due to the asymptomatic nature
of the infection and lack of laboratory diagnostic facilities. In a previous study, the sero-preva-
lence of genital chlamydial infection among Ethiopian women was shown to be 62%with42%
havingtiters suggestive of recent or present genital infection. In the same study, factors found
to be associated with the infection were age at first coitus, religion, prostitution, number of sex-
ual partners and present age of the woman [8]. However, further investigations on the epide-
miology of genital chlamydial infection in Ethiopiaare required to understand whether the
country’s comprehensive and expanded human immunodeficiency virus (HIV)responseshave
impacted the significance of CT infection. This study wasconducted to generateevidence
oncurrent prevalence and associated risk factors of genital chlamydial infection among
women of reproductive agein order to inform decision makers, service providers and other
concerned bodies for possible interventions.
Methods
Ethical clearance
The study was ethically approved by the Institutional Review Board of College of Medicine
and Health Sciences, Hawassa University. Participation was fully voluntary and informed writ-
ten consent was obtained from all participants prior to their participation in the study.
Parents/guardians gave verbally informed assentfor patients aged 15–17 years. Patient infor-
mation was anonymized and de-identified prior to analysis. Screening of participants for
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genital CTand N. gonorrhoeae infections was performed free of charge and those found posi-
tive were managed by a physician. Any information obtained during the study was kept
confidential.
Study design, area and period
A cross-sectional study was carried out to investigate women attending the gynecology clinic
of Hawassa University Referral Hospital in southern Ethiopia from November 2014 to April
2015. The hospital is located at Hawassa, the Capital City of the Southern Nations, Nationali-
ties and Peoples’ Region (SNNPR). The hospital (with 400-bed capacity)is the largest in the
regional state and provides health care for large numbers of patients.
Study population
A consecutive group of 322 women aged between 15 and 49 years with or without symptoms
of STIs and attending the Gynecology clinic for family planning, infertility examination or
diagnosis and treatment services of STIs was enrolled. Women who were pregnant, had taken
antibiotics within the last four weeks or had abnormal bleeding at the time of diagnosis were
excluded from the study.
Data collection
Socio demographic and clinical data collection. After obtaining informed written con-
sent from the study participants, two trained nurses collected data on socio-demography, sex-
ual history, behavioral factors and clinical symptoms using structured questionnaires.
Subsequently, a gynecologist did a genital examination and then the clinical diagnoses were
collected.
Sample collection and testing. Two endocervical swab specimens were collected asepti-
cally from each participant; one for gonococcal culture, and one for CT antigen testing by a
gynecologist using two Dacron-tipped swabs individually. A swab forrapid CT antigen test
was performed immediately at the clinic; and a second swab, for isolation of N. gonorrhoeae,
was placed into a capped tube and delivered to the laboratory immediately.
Isolation of N. gonorrhoeae. The swab samples received in the laboratory were inoculated
into the Modified Thayer Martin agar, placed in an anaerobic jar with 5–10% CO2, and incu-
bated at 37˚C. Bacterial growth was checked every 24 hours for 72 hours. Bacterial isolates
were identified based on their characteristic appearance, Gram reaction and pattern of bio-
chemical reactions [9]. A reference strain of N. gonorrhoeae(ATCC 49226) was tested as a
control.
Testing for CT antigen. CTantigen was detected by a laboratory technologist in the gyne-
cology clinicusing the SD BIOLINE rapid antigen test kit (Standard Diagnostic Inc., Korea).
Thisis a solid phase immunochromatographic assay for the rapid, qualitative detection of
CTantigen directly from an endocervical swab. Tests were performed according to the instruc-
tions of the manufacturer. Briefly, to extract Chlamydia antigen, a swab was inserted in a tube
containing 300 μL reagent A (sample digesting reagent) and incubated for 2 minutes. After
mixing, 600μl of reagent B was added and mixed by rotating the swab 10 times. Then, the swab
was discarded from the tube and the tube was assembled by dropping cap. Four drops of this
extract was added into the sample well. The result was read at 15 min. A positive test result
wasindicated when control (C) and test line (T) were visible. Anegative result was marked only
by a visible control line(C). In case the control line did not appear, the result was interpreted
as invalid and the test was repeated. The sensitivity and specificity of the test kit was 93.1% and
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98.8%, respectively [10]. Samples positive for CT antigen were re-tested asecond time by the
same method.
Operational definitions
Unprotected sex. Study participants who practiced sex without condom use in the previ-
ous 6 months.
Urethritis cases. Patients reporting either dysuria and/or vaginal discharge at the time of
diagnoses.
Data analysis. Data entry and analysis were performed using Statistical Package for Social
Science (SPSS) version-16, and results are summarized using descriptive statistics. Multivari-
able logistic regression analysis was performed by taking those socio-demographic and risk
factors found to be significantly associated with chlamydial infection in bivariate logistic
regression analysis. Odds ratio (OR) with 95% confidence interval was used to measure the
degree of association between dependent and independent variables. A p-value < 0.05 was
considered to be statistically significant.
Results
Participant characteristics
A total of 329 women of reproductive age group attending the gynecology clinic were
approached during the study period. Of these, seven (2.1%) refused to consent and were
excluded. Thus, data from 322 women was considered for analysis. The majority (77.3%) of
the study participants were married with a mean age of 29.6 years (standard deviation (SD),
8.2; range, 15–49 years). Among the women who participated, 28.3% were between 15–24
years of age, 39.4% were between 25–34 years of age and 32.3% were between 35–49 years of
age. Concerning the educational status and residence, 34.2% were illiterate and 53.7% were
rural dwellers. Among the study participants, 69.3% had one lifetime partner and 92.5% prac-
ticed unprotected sex within the last 6 months. The majority (70.2%) of study participants had
no history of pre-marital sex and had not ever used any type of contraceptive methods
(Table 1).
Prevalence and associated risk factors
The overall prevalence was 18.9% (61/322) for CT and 0.31% (1/322) for N. gonorrhoeae.
Women aged 15–24 years had the highest prevalence of CT infection (24.2%) followed by
those aged 25–34 years (16.8%) and those aged 35–49 years (9.6%)(p<0.05).
In bivariate analysis, the prevalence of CT significantly decreased as age increased: women
aged 15–24 and 25–34years were almost 3 times (COR = 2.997; 95% CI 1.334–6.734; p = 0.008)
and 2.7 times (COR = 2.782; 95% CI 1.285–6.022; p = 0.009) more likely infected with CT,
respectively, as compared to women aged 35–49 years. Women having unprotected sex (no
condom use) within the last 6 months were about 3.5 times (COR = 3.459, 95% CI: 1.459–
8.222; p = 0.005) more likely infected with CT as compared to those who used condoms.
Women who weresexually active for less than a year (COR = 3.437, 95% CI: 1.381–8.551;
p = 0.008) or for 1–5 years (COR = 2.917; 95% CI 1.263–6.737; p = 0.012) or for 6–10 years
(COR = 3.818; 95% CI 1.583–9.208; p = 0.003) had higher odds of CT infection as compared to
those who were sexually active for more than ten years. Other factors such as education, resi-
dence, marital status, number of lifetime partners, contraceptive usage, and history of pre-
marital sex were not found to be associated with CT infection (Table 1).
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Table 1. Distribution of Chlamydia trachomatis infection by socio-demographic characteristic of women attending the gynecology clinic of
Hawassa University Referral Hospital, 2015.
Variable ParticipantsN (%) CT Pos. N (%) COR(95%CI) p-value aOR(95%CI) p- value
Age group(years)
15–24 91(28.3) 22(24.2) 2.997(1.334–6.734) 0.008* 1.716(0.603–4.879) 0.312
25–34 127(39.4) 29(22.8) 2.782(1.285–6.022) 0.009* 1.741(0.696–4.358) 0.236
35–49 104(32.3) 10(9.6) 1 1
Residence
Rural 173(53.7) 34(19.7) 1.105(0.631–1.936) 0.726 - -
Urban 149(46.3) 27(18.1) 1
Marital status
Married 249(77.3) 45(18.1) 2.426(0.305–19.276) 0.402 - -
Single 48(14.9) 12(25.0) 3.667(0.428–31.441) 0.236 - -
Divorced 13(4.0) 3(23.1) 3.300(0.294–37.103 0.334 - -
Widowed 12(3.7) 1(8.3) 1
Education
Illiterate 101(34.2) 14(13.9) 1
1–6 grade 72(22.4) 17(23.6) 2.119(0.970–4.629) 0.059 - -
7–12 grade 64(19.9) 13(20.3) 1.748(0.764–4.000) 0.186 - -
>12 grade 76(23.6) 17(22.4) 1.976(0.907–4.302) 0.086 - -
Life time partner
0 24(7.3) 8(33.3) 2.434(0.972–6.094) 0.057 - -
1 223(69.3) 38(17.0) 1 - -
2 75(23.3) 15(20.0) 1.217(0.626–2.366) 0.52 - -
Unprotected sex within the last 6 months
Yes 24(7.5) 10(41.7) 3.459(1.459–8.222) 0.005* 3.314(1.334–8.232) 0.010*
No 298(92.5) 51(17.1) 1 1
Number of sexually active years
<1 57(17.7) 14(24.6) 3.437(1.381–8.551) 0.008* 2.149(0.688–6.716) 0.188
1–5 97(30.1) 21(21.6) 2.917((1.263–6.737) 0.012* 2.931(0.751–5.634) 0.161
6–10 64(19.9) 17(26.6) 3.818(1.583–9.208) 0.003* 3.076(1.152–8.209) 0.025
>10 104(32.3) 9(8.7) 1 1
Use of contraceptive
Yes 96(29.8) 20(20.8) 1.187(0.653–2.158) 0.573 -
No 226(70.2) 41(18.1) 1 -
Type of contraceptive
Pills 10(10.4) 1(10.0) 1
IUCD 11(11.5) 1(9.1) 0.9(0.049–16.594) 0.944 - -
Implant 26(27.1) 6(23.7) 2.700(0.282–25.834) 0.389 - -
Injectable 49(51.0) 12(24.5) 2.919(0.335–25.467) 0.335 - -
Pre-marital sex
Yes 96(29.8) 20(20.8) 1.187(0.653–2.158) 0.573 - -
No 226(70.2) 41(18.1) 1
* Significant association;
CT, Chlamydia trachomatis; Pos, positive; CI, confidence interval; N, total number; COR, crude odds ratio; aOR, adjusted odds ratio; 1–6 grade,
Elementary school; 7–12 grade, Junior and high school; >12 grade, College and University; IUCD, intrauterine contraceptive device.
doi:10.1371/journal.pone.0168580.t001
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In further analysis, after adjustment for those significantly associated variables using multi-
variable logistic regression, the risk of having CT remained significantly higher in women who
had unprotected sex within the last 6 months (aOR = 3.314; 95% CI: 1.334–8.232; p = 0.010)
and were sexually active for 6–10 years (aOR = 3.076; 95% CI 1.152–8.209; p = 0.025) as com-
pared to their counterparts (Table 1).
Clinical symptoms and signs
Regarding clinical symptoms and signsrelated to genital infection, the most frequent symp-
toms reported by study participants were lower abdominal pain (77.6%) followed by vaginal
discharge (37.6%), adnexal tenderness (33.2%), urethritis (16.8%), vaginal bleeding (16.1%),
cervical excitation (13.0%), dysuria (8.1%) and bilateral masses (5.6%). None of theassessedcli-
nical symptoms was found to be associated with CT infection(Table 2).
Clinical diagnoses
Of the study participants examinedby a gynecologist, 21.1% of the women had a history of PID
and 26.4% a history of infertility. Of these, CT infection was found in 20.0% (17/85) of the
infertile women and 14.7% of PID patients. Ninety-six (29.8%) of study participants had had
Table 2. Association between Chlamydia trachomatis infection and clinical symptoms among women attending the gynecology clinic of Hawassa
University Referral Hospital, 2015.
Clinical symptom Participants N (%) CT positive N (%) COR(95%CI) p- value
Lower abdominal pain
Yes 250(77.6) 44(17.6) 1
No 72(24.4) 17(23.6) 1.447(0.768–2.728) 0.253
Adnexal tenderness
Yes 107(33.2) 19(17.1) 1
No 215(66.8) 42(19.5) 1.124(0.617–2.048) 0.701
Cervical excitation
Yes 42(13.0) 8(19.0) 1.008(0.441–2.302) 0.985
No 280(87) 53(18.9) 1
Bilateral masses
Yes 18(5.6) 2(11.1) 1
No 304(94.4) 59(19.4) 1.927(0.431–8.610) 0.391
Vaginal discharge
Yes 121(37.6) 21(17.4) 1
No 201(62.4) 40(19.9) 1.183(0.660–2.122) 0.573
Vaginal bleeding
Yes 52(16.1) 6(11.5) 1
No 270(83.9) 55(20.4) 2.012(0.816–4.963) 0.129
Dysuria
Yes 26(8.1) 2(7.7) 1
No 296(91.9) 59(19.9) 3.090(0.709–13.477) 0.133
Urethritis
Yes 137(42.5) 23(16.8) 1
No 185(57.5) 38(20.5) 1.078 (0.440–1.384)
CT, Chlamydia trachomatis; N, total number; CI, confidence interval; COR, crude odds ratio.
doi:10.1371/journal.pone.0168580.t002
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an abortion, of whom 45.8% had a history of two or more abortions. None of the clinical diag-
noses was found to be significantly associated with CT infection (Table 3).
Discussion
In Ethiopia, laboratory diagnosis of CT infection is not carried out; as a result, urogenital infec-
tion due to CT may be considered to be another STI. The actual burden of the disease is not
known and management is based on a syndromic approach. Lack of information regarding
the prevalence of urogenital CT infection in Ethiopia is also an echo of the absence of specific
and rapid diagnostic tests in the country. Thestudy here provides current information on the
status of an infection; based on this an intervention strategy could be designed. To the best of
our knowledge, this is the first study to provide data on prevalence and risk factors of CT infec-
tion in women of reproductive age in Ethiopia.
In thestudy reported here, the overall prevalence of CT antigen among women attending
the gynecology clinic was 18.9%. Although the majority of our participants were married and
had a single lifetime partner, live in rural areas and did not engage in pre-marital sex, i.e. all
low-risk factors for STIs, this finding is comparable with the study done in Nigeria (18.2%)
[11], Taiwan (18.4%) [12], Gaza, Palestine (20.2%) [13]and the Solomon Islands (20.3%) [14].
Itis possible that the prevalence of CT infection reported in our study represents a true picture
of the disease since the reported condom usage was very low, which may suggest further inves-
tigation of other risk behaviors like non-monogamous spouses [15]. In contrast to our finding,
higher rates of CT infection were reported in women attending gynecology clinics in Mbarara,
Uganda (26.5%) [16], Jos, Nigeria (51.6%) [17]and South Eastern Nigeria(40.7%) [18]. How-
ever, lower rates of CT was reported in Western Kenya (3%) [19], North Western Nigeria
(9.6%) [15]and Iran (8.3%) [20]. These disparities in prevalence rates could be due to a varying
distribution of risk factors in different populationand geographical regions as well as different
laboratory methods, which may have different sensitivity and specificity [16, 17].
In this study, a high prevalence of CT infection was reported in the 15–24 age group
(24.2%), followed by the 25–44age group (16.8%), showing aninverse relation with age. Simi-
larly, higher infection rates were shown in the 15–24 age group elsewhere [12, 21]. Therefore,
the prevalence of CT in adolescent females in this country is an important health concern
Table 3. Chlamydia trachomatis in relation to clinical diagnoses among women attending the gynecology clinic of Hawassa University Referral
Hospital, 2015.
Clinical outcomes Participants N (%)(N = 322) CT positive N (%) COR(95%CI) p- value
History of abortion
Yes 96(29.8) 18(18.8) 1.00(0.543–1.843) 0.999
No 226(70.2) 43(18.9) 1
Frequency of abortion
One 52(54.2) 9(17.3) 1
Two and above 44(45.8) 9(20.5) 1.229(0.440–3.428) 0.694
History of infertility
Yes 85(26.4) 17(20.0) 1.097(0.587–2.047) 0.772
No 237(73.6) 44(18.6) 1
History of PID
Yes 68(21.1) 10(14.7) 1
No 254(78.9) 51(18.9) 1.457(0.697–3.048) 0.317
CT, Chlamydia trachomatis; N, total number; COR, crude odds ratio; PID, pelvic inflammatory disease.
doi:10.1371/journal.pone.0168580.t003
Genital Chlamydia trachomatis Infection among Women of Reproductive Age
PLOS ONE | DOI:10.1371/journal.pone.0168580 December 22, 2016 7 / 11
since untreated CT infection may be a reservoir for ongoing transmission in the population
and could have long-term consequences, which may not manifest themselves until women
later try to conceive.
Unprotected sex practice puts a woman at risk of both unwanted pregnancy and sexually
transmitted infections. In this study, women who practiced unprotected sex within the last six
months and were sexually active for 6 to 10 years had about 3.3 times and 3 times higher odds
of CT infection, respectively, compared to their counterparts. Similar findings have been
reported in other studies [12, 22]. In contrast with previous literature, marital status [15] and
other factors that might be associated with CT, including urban residence [16], multiple sexual
partners [8], and pre-marital sex were not found to be significant risk factors in this study. In
Ethiopia, it was difficult to obtain information regarding sexual behavior because of socio-cul-
tural inhibitions. As a result, participants may have been reluctant to disclose some behaviors,
such as multiple lifetime partners and pre-marital sex, which may have limited our ability to
detect such associations.
In this study, none of the clinical symptoms and signs correlated with the presence of infec-
tion, which suggests that syndromic management alone is unlikely to have a major public
health impact in controlling CT infection [23]. This is consistent with previous studies [23–25]
that reported the absences of symptom(s) in many women with CT infection. Infected women
who are untreated in a timely and effective manner may be at a higher risk of developing gyne-
cological complications [24–26]. A study has shownthat there is a probability of 16% that CT
infection will result in PID [7], in line with our finding that 14.7% of CT positive women had a
history of PID. In this study, 20% of women with a history of infertility have CT infection con-
cordant with a study in India(18.6%) [27]that showed significant association between current
CTinfection andinfertility. Similarly, 20.5% of women who had a history of two or more abor-
tions had CT infection. This needs a further follow-up study to confirm the association of CT
infection with infertility and recurrent abortion in Ethiopia.
In this study, we found a low prevalence of N. gonorrhoeae, which is similar to rates found
in other studies [19,28,29]. However, high rates of prevalence were previouslyreported in Ethi-
opia [30, 31]. The low prevalence rate in our study may be due to difference in the study sub-
jects. In the previous study, only symptomatic cases were enrolled while our study included
both symptomatic and asymptomatic cases. In addition, swab transport systems were used in
our study in contrast to the study conducted in Northwest Ethiopia [30], which used immedi-
ate inoculation to modified Thayer Martin media, which is a method preferred over swab
transport systems [32].
The findings in this report have some limitations in light of which results need be inter-
preted. First, ours was a hospital-based study that used a non-probability sampling method:
this may hinder the generalizability of the result to all women of a reproductive age in Ethiopia.
Second, due to lack of access, nucleic acid amplification tests (NAATs) was not performed.
Despite the above limitations, our study has the strength that CT antigen was detected directly
from an endocervical swab using a point-of- care test, indicating active infection in both
asymptomatic and symptomatic cases. Moreover, the study may serve as baseline information
for further large-scale studies on the general population in the country.
Conclusion
Relatively high prevalence of CT and low prevalence of gonococcal infection among women of
reproductive age wereobserved, especially among those participants who had unprotected sex
(no condom use) within the last six months and had been sexually active for 6 to 10 years.
Despite its shortcomings, this study provides a strong foundation for the initiation of
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screening and treatment programs for CT in high-risk populations, particularly among young
women aged 15 to 24 years to stem the spread of this infection.
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